The Real Reason Trials Fail Isn’t Recruitment… It’s Design

  • Why most oncology trial delays are designed in before the first patient is enrolled
  • How Pharma, Biotech and CRO teams are using AI to eliminate amendments before they happen
  • What it takes to build a protocol that actually works operationally, globally, and regulator-ready from day one

PATIENT ADVOCATE AND SITE SPOTLIGHT Cultural Change in Clinical Trial Development with a Patient and Sites Expert Panel

  • Establishing a panel of patients, researchers and healthcare professionals: How a standing panel of experts provides ongoing insights that help shape research, clinical trial development, participant-facing materials and decision-making.
  • Turning lived experience into action: Real examples of how panel feedback has influenced communication materials.
  • Driving cultural change through partnership: How co-creating and co-delivering training on cultural sensitivity, social determinants of health, and unconscious bias helps clinical trial managers to ensure more inclusive clinical research practices.
  • Awards to drive culture change: How evaluating award submissions and celebrating great patient and site engagement examples helps drive a culture change.

PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

LIVE DEBATE Are large CRO operating models equipped to support the agility and priorities of small biotechs?

  • Navigating traditional and niche CRO models as an emerging biotech
  • Understanding the key differences between big pharma and biotech approaches to clinical trial execution and outsourcing strategy
  • Examining how niche and specialist vendors are addressing sponsor pain points with more tailored, flexible solutions
  • Identifying how sponsors and providers can better align expectations, communication models, and operational support for successful partnerships

Debater 1: Juliet Dizon, Director, Pre-Clinical and Clinical Quality Assurance, ARTBIO

Debater 2: Antje Hindahl, Head Strategic Clinical Vendor Management, Argenx

Moderator: Available